553 related articles for article (PubMed ID: 34633681)
21. 2021 World Health Organization Classification of Brain Tumors.
Meredith DM; Pisapia DJ
Continuum (Minneap Minn); 2023 Dec; 29(6):1638-1661. PubMed ID: 38085892
[TBL] [Abstract][Full Text] [Related]
22. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas.
Shirahata M; Ono T; Stichel D; Schrimpf D; Reuss DE; Sahm F; Koelsche C; Wefers A; Reinhardt A; Huang K; Sievers P; Shimizu H; Nanjo H; Kobayashi Y; Miyake Y; Suzuki T; Adachi JI; Mishima K; Sasaki A; Nishikawa R; Bewerunge-Hudler M; Ryzhova M; Absalyamova O; Golanov A; Sinn P; Platten M; Jungk C; Winkler F; Wick A; Hänggi D; Unterberg A; Pfister SM; Jones DTW; van den Bent M; Hegi M; French P; Baumert BG; Stupp R; Gorlia T; Weller M; Capper D; Korshunov A; Herold-Mende C; Wick W; Louis DN; von Deimling A
Acta Neuropathol; 2018 Jul; 136(1):153-166. PubMed ID: 29687258
[TBL] [Abstract][Full Text] [Related]
23. [Update on primary brain tumours].
Wirsching HG; Weller M
Ther Umsch; 2018; 75(7):438-443. PubMed ID: 30935361
[TBL] [Abstract][Full Text] [Related]
24. Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.
Yuan F; Wang Y; Ma C
Curr Treat Options Oncol; 2022 Feb; 23(2):188-198. PubMed ID: 35182297
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of molecular analysis in diffuse glioma stratification.
Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Sangatsuda Y; Fujioka Y; Takigawa K; Funakoshi Y; Suzuki SO; Iwaki T
Brain Tumor Pathol; 2021 Jul; 38(3):210-217. PubMed ID: 34268651
[TBL] [Abstract][Full Text] [Related]
26. Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.
Petersen JK; Boldt HB; Sørensen MD; Blach S; Dahlrot RH; Hansen S; Burton M; Thomassen M; Kruse T; Poulsen FR; Andreasen L; Hager H; Ulhøi BP; Lukacova S; Reifenberger G; Kristensen BW
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):108-126. PubMed ID: 32696543
[TBL] [Abstract][Full Text] [Related]
27. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
[TBL] [Abstract][Full Text] [Related]
28. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.
Sonoda Y
Int J Clin Oncol; 2020 Jun; 25(6):1004-1009. PubMed ID: 32020379
[TBL] [Abstract][Full Text] [Related]
29. The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision.
Komori T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):301-311. PubMed ID: 28592714
[TBL] [Abstract][Full Text] [Related]
30. Review of the Recent Changes in the WHO Classification for Pediatric Brain and Spinal Cord Tumors.
Halfpenny AM; Wood MD
Pediatr Neurosurg; 2023; 58(5):337-355. PubMed ID: 36617415
[TBL] [Abstract][Full Text] [Related]
31. [The 2021 WHO Classification of Tumors, 5th edition, Central Nervous System Tumors: A Short Review].
Komori T
Brain Nerve; 2022 Jun; 74(6):803-809. PubMed ID: 35676215
[TBL] [Abstract][Full Text] [Related]
32. Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors.
Ramkissoon SH; Fernandes H; Lopez-Terrada DH; Hameed MR; Trembath DG; Bridge JA; Lindeman NI; Souers RJ; Vasalos P; Brat DJ; Moncur JT
Arch Pathol Lab Med; 2022 May; 147(5):518-524. PubMed ID: 35878398
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Performance of [
Nakajo K; Uda T; Kawashima T; Terakawa Y; Ishibashi K; Tsuyuguchi N; Tanoue Y; Nagahama A; Uda H; Koh S; Sasaki T; Ohata K; Kanemura Y; Goto T
World Neurosurg; 2021 Apr; 148():e471-e481. PubMed ID: 33444827
[TBL] [Abstract][Full Text] [Related]
34. [Neuropathology of pediatric brain tumors : Implications of the 5th edition of the WHO classification of central nervous system tumors].
Reyes Medina B; Wrede A; Schulz-Schaeffer WJ
Radiologie (Heidelb); 2023 Aug; 63(8):577-582. PubMed ID: 37477671
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma: Changing concepts in the WHO CNS5 classification.
Chen J; Han P; Dahiya S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S24-S32. PubMed ID: 35562131
[TBL] [Abstract][Full Text] [Related]
36. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
37. Major Features of the 2021 WHO Classification of CNS Tumors.
Smith HL; Wadhwani N; Horbinski C
Neurotherapeutics; 2022 Oct; 19(6):1691-1704. PubMed ID: 35578106
[TBL] [Abstract][Full Text] [Related]
38. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.
Malzkorn B; Reifenberger G
Pathologe; 2019 Jun; 40(Suppl 1):9-17. PubMed ID: 31025086
[TBL] [Abstract][Full Text] [Related]
39. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
Fuller CE; Jones DTW; Kieran MW
Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
[TBL] [Abstract][Full Text] [Related]
40. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski C; Nabors LB; Portnow J; Baehring J; Bhatia A; Bloch O; Brem S; Butowski N; Cannon DM; Chao S; Chheda MG; Fabiano AJ; Forsyth P; Gigilio P; Hattangadi-Gluth J; Holdhoff M; Junck L; Kaley T; Merrell R; Mrugala MM; Nagpal S; Nedzi LA; Nevel K; Nghiemphu PL; Parney I; Patel TR; Peters K; Puduvalli VK; Rockhill J; Rusthoven C; Shonka N; Swinnen LJ; Weiss S; Wen PY; Willmarth NE; Bergman MA; Darlow S
J Natl Compr Canc Netw; 2023 Jan; 21(1):12-20. PubMed ID: 36634606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
